Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Drugs For Erectile Dysfunction Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global drugs for erectile dysfunction market is projected to experience moderate growth, increasing from $3.21 billion in 2022 to $3.25 billion in 2023 at a Compound Annual Growth Rate (CAGR) of 1.3%. Over the forecast period from 2023 to 2027, the market is expected to grow to $3.36 billion at a CAGR of 0.8%.
Regional Insights:
- North America is the largest market for erectile dysfunction drugs in 2022.
- The Middle East is expected to be the fastest-growing region in the forecast period.
Types of Drugs in Erectile Dysfunction (ED) Drugs Market:
- Sildenafil citrate
- Mirodenafil
- Vardenafil
Routes of Administration:
- Oral
- Topical
- Injections
Distribution Channels:
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Market Driver:
- The drastic increase in the number of chronic diseases is driving the erectile dysfunction drug market. Chronic diseases resulting from a sedentary lifestyle, such as cardiovascular diseases, diabetes, obesity, and high blood pressure, are the main causes of erectile dysfunction.
Market Restraints:
- Lack of education, awareness, strong religious beliefs, social taboos, and low socioeconomic status lead to patients suffering from erectile dysfunction rejecting or avoiding treatment.
- Factors such as lack of awareness about the link between erectile dysfunction and other health conditions like high blood pressure, elevated cholesterol, and diabetes restrain the growth of the market.
Market Opportunities:
- New drug delivery techniques like pellets and creams are being implemented by many companies, which may have more efficacy and performance in treating erectile dysfunction.
- Drug delivery techniques like pellets and creams may also be safer to use and increase the scope of the erectile dysfunction drug market.
Regulatory Landscape:
- Medicines in the erectile dysfunction market are authorized by regulatory bodies based on quality, safety, and efficacy to ensure standard quality and positive benefits for patients.
- Companies are mandated to submit documentation for standard quality before applying for authorization, and clinical trials are required for all new medicines to demonstrate safety and efficacy.
Major Players in the Market:
- Eli Lilly and Co.
- Pfizer
- Bayer AG
- Dong-A Pharmaceutical Co. Ltd
- Vivus
- Meda Pharmaceuticals
- Apricus Biosciences
- Cristalia
- S.K. Chemicals Co
- Teva Pharmaceutical Industries Ltd.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2023-2027 |
| Estimated Market Value (USD) in 2023 | $3.25 Billion |
| Forecasted Market Value (USD) by 2027 | $3.36 Billion |
| Compound Annual Growth Rate | 0.8% |
| Regions Covered | Global |
Key Topics Covered
1. Executive Summary
2. Drugs For Erectile Dysfunction Market Characteristics
3. Drugs For Erectile Dysfunction Market Trends And Strategies
4. Drugs For Erectile Dysfunction Market - Macro Economic Scenario
4.1 COVID-19 Impact On Drugs For Erectile Dysfunction Market
4.2 Ukraine-Russia War Impact On Drugs For Erectile Dysfunction Market
4.3 Impact Of High Inflation On Drugs For Erectile Dysfunction Market
5. Drugs For Erectile Dysfunction Market Size And Growth
5.1. Global Drugs For Erectile Dysfunction Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Drugs For Erectile Dysfunction Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Drugs For Erectile Dysfunction Market Segmentation
6.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Sildenafil Citrate
- Mirodenafil
- Vardenafil
6.2. Global Drugs For Erectile Dysfunction Market, Segmentation By End users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
6.3. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Oral
- Topical
- Injections
7. Drugs For Erectile Dysfunction Market Regional And Country Analysis
7.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
A selection of companies mentioned in this report includes:
- Eli Lilly and Co.
- Pfizer
- Bayer AG
- Dong-A Pharmaceutical Co. Ltd.
- Vivus
- Meda Pharmaceuticals
- Apricus Biosciences
- Cristalia
- S.K. Chemicals Co.
- Teva Pharmaceutical Industries Ltd.
- Produtos Quimicos Farmaceuticos Ltd.
- Johnson & Johnson Services
- Bonro Medical
- Post-T-Vac Medical
- Augusta Medical Systems LLC (Augusta Medical)
- Zephyr Surgical Implants (ZSI)
- Premedon
- Futura Medical
- Endo International plc
- Coloplast A/S
- Boston Scientific Corp
- Seelos Therapeutics
For more information about this report visit https://www.researchandmarkets.com/r/3zvzot
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
